Education
About Us
Working with TipRanks
Follow Us
Recordati Industria Chimica e Farmaceutica SPA (IT:REC)
:REC
RESEARCH TOOLSreports
Total Valuation
Recordati Industria Chimica e Farmaceutica SPA has a market cap or net worth of €11.01B. The enterprise value is €9.40B.
Market Cap€11.01B
Enterprise Value€9.40B
Share Statistics
Recordati Industria Chimica e Farmaceutica SPA has 209,125,150 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding209,125,150
Owned by Insiders0.13%
Owned by Institutions―
Financial Efficiency
Recordati Industria Chimica e Farmaceutica SPA’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 11.50%.
Return on Equity (ROE)0.22
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)11.50%
Return on Capital Employed (ROCE)0.15
Revenue Per Employee511.26K
Profits Per Employee90.94K
Employee Count4,580
Asset Turnover0.46
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Recordati Industria Chimica e Farmaceutica SPA is 25.06. Recordati Industria Chimica e Farmaceutica SPA’s PEG ratio is -1.36.
PE Ratio25.06
PS Ratio0.00
PB Ratio5.15
Price to Fair Value5.56
Price to FCF21.80
Price to Operating Cash Flow17.25
PEG Ratio-1.36
Income Statement
In the last 12 months, Recordati Industria Chimica e Farmaceutica SPA had revenue of 2.34B and earned 416.51M in profits. Earnings per share was 2.02.
Revenue2.34B
Gross Profit1.60B
Operating Income638.90M
Pretax Income547.18M
Net Income416.51M
EBITDA795.37M
Earnings Per Share (EPS)2.02
Cash Flow
In the last 12 months, operating cash flow was 569.92M and capital expenditures -52.02M, giving a free cash flow of 519.72M billion.
Operating Cash Flow569.92M
Free Cash Flow519.72M
Free Cash Flow per Share2.49
Dividends & Yields
Recordati Industria Chimica e Farmaceutica SPA pays an annual dividend of €1.27, resulting in a dividend yield of 2.51%
Dividend Per Share€1.27
Dividend Yield2.51%
Payout Ratio99.54%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.60
52-Week Price Change12.29%
50-Day Moving Average51.90
200-Day Moving Average51.98
Relative Strength Index (RSI)51.26
Average Volume (3m)304.99K
Important Dates
Recordati Industria Chimica e Farmaceutica SPA upcoming earnings date is Jul 30, 2025, TBA (Confirmed).
Last Earnings DateMay 8, 2025
Next Earnings DateJul 30, 2025
Ex-Dividend DateMay 19, 2025
Financial Position
Recordati Industria Chimica e Farmaceutica SPA as a current ratio of 1.61, with Debt / Equity ratio of 111.01%
Current Ratio1.61
Quick Ratio1.61
Debt to Market Cap<0.01
Net Debt to EBITDA-0.38
Interest Coverage Ratio7.83
Taxes
In the past 12 months, Recordati Industria Chimica e Farmaceutica SPA has paid 130.68M in taxes.
Income Tax130.68M
Effective Tax Rate0.24
Enterprise Valuation
Recordati Industria Chimica e Farmaceutica SPA EV to EBITDA ratio is 12.75, with an EV/FCF ratio of 18.95.
EV to Sales4.33
EV to EBITDA12.75
EV to Free Cash Flow18.95
EV to Operating Cash Flow17.79
Balance Sheet
Recordati Industria Chimica e Farmaceutica SPA has €322.42M in cash and marketable securities with €22.84M in debt, giving a net cash position of -€299.58M billion.
Cash & Marketable Securities€322.42M
Total Debt€22.84M
Net Cash-€299.58M
Net Cash Per Share-€1.43
Tangible Book Value Per Share-€6.95
Margins
Gross margin is 69.42%, with operating margin of 27.29%, and net profit margin of 17.79%.
Gross Margin69.42%
Operating Margin27.29%
Pretax Margin23.37%
Net Profit Margin17.79%
EBITDA Margin33.97%
EBIT Margin26.83%
Analyst Forecast
The average price target for Recordati Industria Chimica e Farmaceutica SPA is €57.10, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target€57.10
Price Target Upside6.83% Upside
Analyst ConsensusHold
Analyst Count5
Revenue Growth Forecast12.85%
EPS Growth Forecast7.34%